STANISLAW R. BURZYNSKI, M.D.

STANISLAW R. BURZYNSKI, M.D., Ph.D. was born in Poland. He graduated first in his medical school class from the Medical Academy in Lublin, Poland in 1967. In 1968, he earned his Ph.D. in Biochemistry, being the youngest person ever to receive this Degree in conjunction with his Medical Degree. Dr. Burzynski did his Internship and Residency in Lublin.

Dr. Burzynski came to America in 1970, joining the faculty of the Baylor College of Medicine in Houston, Texas. He spent 7 years at Baylor. In 1977, he opened his own clinic and medical research facility. Since that time, Dr. Burzynski has been in private practice treating primarily cancer patients with pharmaceutical compounds, which he has discovered and named “Antineoplastons.” These compounds are an important part of biochemical defense systems against cancer, and viral infections such as AIDS and are also important in other conditions such as autoimmune diseases, Parkinson’s disease, neurofibromatosis and restenosis.

Dr. Burzynski employs over 130 people in his medical practice, research facility and drug production plant. His clinic has over 20 medical doctors and the research and manufacturing facilities have over a dozen Ph.D.’s and Masters of Science professionals. Dr. Burzynski manufactures virtually all of his own medications for the treatment of his patients.

In 1992, a team of investigators from the National Cancer Institute conducted a site visit and reviewed the complete medical records of 7 terminally ill brain cancer patients. They concluded that in every single case, Dr. Burzynski’s treatment caused a complete or partial remission.

In 1996, after intervention by several congressional committees, the FDA granted Dr. Burzynski permission to pursue almost 70 clinical trials to prove the efficacy of his treatment. Some of these trials have already reached their endpoint, and others are still continuing. He is the first individual medical doctor who has invented a medical treatment, which as been extensively tested under the FDA’s IND clinical trial process.

Dr. Burzynski has over 160 patents filed on his medications around the world. He has authored almost 200 publications and there are over 100 publications on Antineoplastons by other researchers around the world.
Dr. Burzynski will speak on Antineoplastons Cancer Treatment – Theory & Result.


 


Or for ordering information, click on To order


Return to Home Page.